Biopharmaceuticals
HIV/AIDS
Regulatory
News Release - November 22, 2013
Tivicay(R) (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV
Source: ViiV Healthcare
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.